| Identification | Back Directory | [Name]
Aspartocin D | [CAS]
1211953-97-7 | [Synonyms]
N-[(3Z)-10-methyl-1-oxo-3-undecen-1-yl]-L-α-aspartyl-(2S,3R)-2,3-diaminobutanoyl-(2R)-2-piperidinecarbonyl-(3S)-3-methyl-L-α-aspartyl-L-α-aspartylglycyl-L-α-aspartylglycyl-(2R,3R)-2,3-diaminobutanoyl-L-valyl-L-proline (11→2)-lactam | [Molecular Formula]
C57H89N13O20 | [MOL File]
1211953-97-7.mol | [Molecular Weight]
1276.41 |
| Chemical Properties | Back Directory | [solubility ]
DMF: soluble
DMSO: soluble
Ethanol: soluble
Methanol: soluble | [Sequence]
{Δ3-Isododecenoic acid}-Asp-cyclo({2,3-Dab}-{d-Pip}-{Asp(Me)}-Asp-Gly-Asp-Gly-{2,3-Dab}-Val-Pro) |
| Hazard Information | Back Directory | [Uses]
Aspartocin D is an analogue of Amphomycin (HY-P3078). Aspartocin D shows antimicrobial activities against Gram-positive bacteria[1]. | [References]
[1] Yang HJ, et al. Two novel amphomycin analogues from Streptomyces canus strain FIM-0916. Nat Prod Res. 2014;28(12):861-7. DOI:10.1080/14786419.2014.886210 |
|
|